Connect with us

Health

Canadian patients face long waits for diagnostic imaging

Published

3 minute read

From the Fraser Institute

Polling data from earlier this year is crystal clear—the majority Canadians believe their health-care system has worsened over the past decade and more money won’t fix the problem.

Who could blame them?

This year we’ve seen reports of the regular closing of emergency room services, studies finding that one in five Canadians are without access to a regular a family doctor, and that the country now boasts some of the longest waits for medically necessary surgery in 30 years.

It’s no secret that the rationing of care through long wait times has become the defining characteristic of Canadian health care. In fact, in 2023 Canadians could expect to wait a median of 27.7 weeks for treatment—nearly seven weeks longer than in 2019 and almost three times longer than the 9.3-week wait in 1993.

While bottlenecks can be found nearly everywhere throughout the system, less talked about are the increasingly lengthy waits Canadians face when trying to access timely diagnostic services.

In 2023, reported waits for an MRI were found to be a median of 12.9 weeks—two weeks longer than last year, and the longest on record in at least a decade. We see a similar thing for CT scans where the 6.6-week wait this year is a week longer than last year (and also the longest in at least a decade).

So why the lengthening delays?

One reason is that, when compared to other countries with universal coverage, Canada has some of the lowest availability of key diagnostic imaging technology in the industrialized world despite being one of the highest spenders among the same cohort.

Take CT scanners, for example. In 2019 (the latest year of available data), Canada ranked 26th (of 30 countries) for the number of scanners available. At 14.9 units per million population, this doesn’t even come close to the availability of this technology among top performers such as Japan, which reported having five-and-a-half times as many scanners. We see a similar story with MRI units, where Canada ranks 25th out of 29 countries and reports an availability of stock four times smaller than Japan’s. Canada also had middling to poor results for the volume of diagnostic examinations performed, ranking 13th of 26 for CT scans and 18th out of 26 for MRI exams per thousand population.

Ultimately, poor access to diagnostic imaging not only frustrates the timely triaging of patients, it can also potentially add onto already lengthy waits for scheduled treatment (which again are the longest in at least three decades).

Canadian patients face many challenges in seeking to access timely elective surgical care including lengthy waits for diagnostic services. Improving access to medical imaging is a first step towards improving this access.

Todayville is a digital media and technology company. We profile unique stories and events in our community. Register and promote your community event for free.

Follow Author

Dr John Campbell

Cures for Cancer? A new study shows incredible results from cheap generic drug Fenbendazole

Published on

From Dr. John Campbell

FenBen in Stage 4 cancer

You won’t hear much about Fenbendazole from the regular pipeline of medical information.  There could be many reasons for that. For one, it’s primarily known for it’s use in veterinary medicine.  Somehow during COVID the medical information pipeline convinced millions that if a drug is used on horses or other animals it couldn’t work for humans.  Not sure how they got away with that one considering the use of animal trials for much of modern medical history.

Another possible reason, one that makes at least as much sense, is that there’s no business case for Fenbendazole.  It’s been around for decades and its patent expired in the early 1990’s.  That means it’s considered a generic drug that a pharmaceutical company from India could (and does) produce in mass quantities for very little profit (compared to non-generics).

So Fenbendazole is an inexpensive, widely accessible antiparasitic drug used in veterinary medicine.  During the COVID pandemic a number of doctors, desperate for a suitable treatment, tried it with reportedly great levels of success.  Over some time they discovered it might be useful elsewhere.  Some doctors are using Fenbendazole to help treat late stage cancer.  Often this is prescribed when the regular treatments clearly aren’t working and cancer is approaching or has already been declared stage 4.

What they’ve found at least in some cases is astounding results.  This has resulted in a new study which medical researcher Dr. John Campbell shares in this video.

Continue Reading

Addictions

Canadian gov’t not stopping drug injection sites from being set up near schools, daycares

Published on

From LifeSiteNews

By Anthony Murdoch

Canada’s health department told MPs there is not a minimum distance requirement between safe consumption sites and schools, daycares or playgrounds.

So-called “safe” drug injection sites do not require a minimum distance from schools, daycares, or even playgrounds, Health Canada has stated, and that has puzzled some MPs. 

Canadian Health Minister Marjorie Michel recently told MPs that it was not up to the federal government to make rules around where drug use sites could be located.

“Health Canada does not set a minimum distance requirement between safe consumption sites and nearby locations such as schools, daycares or playgrounds,” the health department wrote in a submission to the House of Commons health committee.

“Nor does the department collect or maintain a comprehensive list of addresses for these facilities in Canada.”

Records show that there are 31 such “safe” injection sites allowed under the Controlled Drugs And Substances Act in six Canadian provinces. There are 13 are in Ontario, five each in Alberta, Quebec, and British Columbia, and two in Saskatchewan and one in Nova Scotia.

The department noted, as per Blacklock’s Reporter, that it considers the location of each site before approving it, including “expressions of community support or opposition.”

Michel had earlier told the committee that it was not her job to decide where such sites are located, saying, “This does not fall directly under my responsibility.”

Conservative MP Dan Mazier had asked for limits on where such “safe” injection drug sites would be placed, asking Michel in a recent committee meeting, “Do you personally review the applications before they’re approved?”

Michel said that “(a)pplications are reviewed by the department.”

Michel said, “Supervised consumption sites were created to prevent overdose deaths.”

Mazier continued to press Michel, asking her how many “supervised consumption sites approved by your department are next to daycares.”

“I couldn’t tell you exactly how many,” Michel replied.

Mazier was mum on whether or not her department would commit to not approving such sites near schools, playgrounds, or daycares.

An injection site in Montreal, which opened in 2024, is located close to a kindergarten playground.

Conservative Party leader Pierre Poilievre has called such sites “drug dens” and has blasted them as not being “safe” and “disasters.”

Records show that the Liberal government has spent approximately $820 million from 2017 to 2022 on its Canadian Drugs and Substances Strategy. However, even Canada’s own Department of Health admitted in a 2023 report that the Liberals’ drug program only had “minimal” results.

Recently, LifeSiteNews reported that the British Columbia government decided to stop a so-called “safe supply” free drug program in light of a report revealing many of the hard drugs distributed via pharmacies were resold on the black market.

British Columbia Premier David Eby recently admitted that allowing the decriminalization of hard drugs in British Columbia via a federal pilot program was a mistake.

Former Prime Minister Justin Trudeau’s loose drug initiatives were deemed such a disaster in British Columbia that Eby’s government asked Trudeau to re-criminalize narcotic use in public spaces, a request that was granted.

Official figures show that overdoses went up during the decriminalization trial, with 3,313 deaths over 15 months, compared with 2,843 in the same time frame before drugs were temporarily legalized.

Continue Reading

Trending

X